enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor 'What This Means' Segment

enVVeno Medical (NASDAQ:NVNO) reported Q2 2026 results and said the FDA granted IDE approval to start its TAVVE pivotal trial for its enVVe System. The company expects enrollment to begin in H2 2026 with about 230 patients across up to 40 sites. Cash and investments were about $21.5M at June 30, 2026, with Q2 net loss of $3.6M.

enVVeno Medical (NASDAQ:NVNO) said the U.S. Patent Office issued U.S. Patent No. 12,575,932 covering components and use methods of its enVVe transcatheter replacement venous valve system for deep venous insufficiency. The company links this to prior FDA IDE approval for its TAVVE pivotal trial, with enrollment to start and first patient data expected by end of Q4 2026.

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.